NCT04593420
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Ipsen Central Contact Paris, France
Clinical trial condition
Prostatic Diseases
Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.
5,360 public trials
1,050 recruiting studies
Prostatic Diseases trial results
NCT04178811
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Faculty of Medicine Assiut University Asyut, Egypt
NCT04936243
- Conditions
- Behavior, Breast Cancer, Breast Diseases, +21 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT04853095
- Conditions
- Cysts, Genital Diseases, Genital Diseases, Male, +13 more
- Locations
-
- University hospital Olomouc Olomouc, Czechia
NCT04862533
- Conditions
- Beta-alanine, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +20 more
- Locations
-
- University hospital Olomouc Olomouc, Czechia
NCT02710721
- Conditions
- Behavior, Fasting, Feeding Behavior, +10 more
- Locations
-
- Charité Centrum Chirurgische Medizin, CC 8 Klinik für Urologie Berlin, Germany
NCT02054013
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Cantonal Hospital St. Gallen Sankt Gallen, Switzerland
NCT00547339
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
- MD Anderson Cancer Center Orlando Florida Orlando, Florida, United States
- University of Minnesota Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
- Prairie Lakes Cancer Center Watertown, South Dakota, United States
NCT02812173
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +17 more
- Locations
-
- Department of Urology, Pediatric Urology and Urologic Oncology, St. Antonius Hospital Gronau Gronau, Germany
Completed
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
NCT02643303
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Cancer, +65 more
- Locations
-
- Research Facility Atlanta, Georgia, United States
- Research Facility Lebanon, New Hampshire, United States
- Research Facility Buffalo, New York, United States
- Research Facility New York, United States